It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2011
  5. Otsuka receives approval for Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as in vitro diagnostic on June 13

June 15, 2011

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

Otsuka receives approval for Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as in vitro diagnostic on June 13

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it obtained approval for manufacturing and marketing of its Streptococcus pneumoniae antigen detection reagent by the immunochromatographic method, "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as an in vitro diagnostic on June 13, 2011.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases